Skip to content

Evaluating the effectiveness of Rehacom computer intervention on the emotional state of adolescents with hyperactivity and brain map changes

Investigating the effect of cognitive-rehabilitation intervention rehacom Quantitative Electroencephalogram based, on emotion regulation in attention deficit-hyperactivity disorder

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231019059769N2
Enrollment
32
Registered
2024-08-28
Start date
2024-09-20
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit hyperactivity. Attention-deficit hyperactivity disorder, combined type

Interventions

Intervention 1: the intervention group will receive RIHACOM cognitive-rehabilitation interventions . Interventions will be carried out for patients using Rihakam cognitive-rehabilitation software for

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
11 Years to 17 Years

Inclusion criteria

Inclusion criteria: Adolescents from the age of 11 to 19 years with ADHD diagnosed by a specialist in child and adolescent psychiatry, The ability to read and write, not having vision, hearing, muscle and physical problems, Not suffering from known co-morbidities such as schizophrenia, autism, low IQ, Not using drugs according to Information received from parents, Family and patient satisfaction

Exclusion criteria

Exclusion criteria: Lack of physical and mental ability to continue the treatment, Using drugs during the intervention, according to the information obtained from the parents, Not participating in more than two intervention sessions.

Design outcomes

Primary

MeasureTime frame
Emotion regulation. Timepoint: Before, immediate after and a month later after intervention. Method of measurement: John and gross emotion regulation questioner.

Countries

Iran (Islamic Republic of)

Contacts

Public Contact?Dr Ladan Zarshenas

Shiraz University of Medical Sciences

?zarshenas@sums.ac.ir+98 917 308 8285

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026